Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Other Non-Current Liabilities (2016 - 2024)

Historic Other Non-Current Liabilities for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $8.1 billion.

  • Sanofi's Other Non-Current Liabilities fell 899.24% to $8.1 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $8.1 billion, marking a year-over-year decrease of 899.24%. This contributed to the annual value of $8.7 billion for FY2024, which is 520.64% up from last year.
  • Sanofi's Other Non-Current Liabilities amounted to $8.1 billion in Q2 2025, which was down 899.24% from $8.7 billion recorded in Q4 2024.
  • Over the past 5 years, Sanofi's Other Non-Current Liabilities peaked at $8.9 billion during Q2 2024, and registered a low of $1.3 billion during Q4 2021.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $8.1 billion (2025), whereas its average is $7.1 billion.
  • Per our database at Business Quant, Sanofi's Other Non-Current Liabilities crashed by 2843.95% in 2021 and then surged by 40583.21% in 2022.
  • Quarter analysis of 5 years shows Sanofi's Other Non-Current Liabilities stood at $1.3 billion in 2021, then surged by 405.83% to $6.5 billion in 2022, then grew by 26.43% to $8.2 billion in 2023, then increased by 5.77% to $8.7 billion in 2024, then dropped by 6.89% to $8.1 billion in 2025.
  • Its Other Non-Current Liabilities stands at $8.1 billion for Q2 2025, versus $8.7 billion for Q4 2024 and $8.9 billion for Q2 2024.